1. Home
  2. LEE vs QTTB Comparison

LEE vs QTTB Comparison

Compare LEE & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lee Enterprises Incorporated

LEE

Lee Enterprises Incorporated

HOLD

Current Price

$4.01

Market Cap

24.7M

ML Signal

HOLD

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$3.03

Market Cap

25.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEE
QTTB
Founded
1890
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.7M
25.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LEE
QTTB
Price
$4.01
$3.03
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$7.33
AVG Volume (30 Days)
17.5K
9.0M
Earning Date
11-26-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$562,341,000.00
N/A
Revenue This Year
$5.48
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.70
$1.35
52 Week High
$16.84
$6.37

Technical Indicators

Market Signals
Indicator
LEE
QTTB
Relative Strength Index (RSI) 39.28 53.39
Support Level $3.90 $3.06
Resistance Level $4.43 $3.96
Average True Range (ATR) 0.38 0.53
MACD -0.00 0.01
Stochastic Oscillator 2.73 24.37

Price Performance

Historical Comparison
LEE
QTTB

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.

Share on Social Networks: